Cardiac disease was once thought to be both progressive and irreversible. As stem cell therapies emerge across many fields of medicine, our patients with cardiac disorders may be among the first to benefit from this translation of basic science into very valuable clinical applications. What do the latest findings tell us about our ability to tap into the promise of stem cells to treat, reverse or even prevent cardiac disease? Dr. Joshua Hare, director of the Interdisciplinary Stem Cell Institute and the Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine, walks us through the most promising developments in this cutting-edge research and provides his insights on how you can talk with your patients about where they can expect to see benefits in the short term. Dr. Janet Wright hosts.